Early Discoveries, With More to Come So far, GLP-1s, first approved 20 years ago for type 2 diabetes and later obesity, have shown potential in treating a surprisingly wide range of conditions, such as heart disease, Parkinsons, Alzheimers, sleep apnea, and liver disease
However, the RCT performance and outcomes are not always reflected in real-world studies, in part because of lower adherence and greater heterogeneity of population [90]
The patients reported history of heroin and tobacco use coupled with his hepatitis C-positive status highlights the significant risk factors for deep vein thrombosis (DVT)
Communicate with Your Doctor: If you have any concerns at all, talk to your prescribing physician or your pharmacist
Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R, Geier MR: Biomarkers of environmental toxicity and susceptibility in autism
Recent genome-wide association studies have also identified LINC00944 as a novel locus associated with blood pressure regulation